Latest Topics of Interest on Radiation Risk Communication: A Decade After Japan’s Fukushima Daiichi Nuclear Power Plant Accident
Disaster Medicine and Public Health Preparedness · 2023
DOI: 10.1017/dmp.2023.194 ↗Kurz gefasst
Leserbrief in der Zeitschrift Disaster Medicine and Public Health Preparedness, 2023. Verfasst von Hitomi Matsunaga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health, Medicine and Welfare Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. Hauptthemen laut MEDLINE: Fukushima Nuclear Accident, Radiation Exposure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Global Health, Medicine and Welfare Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
ORCID-Profile: Hitomi Matsunaga, Noboru Takamura
Zitieren
APA
Matsunaga, H., Orita, M., Xiao, X., Kashiwazaki, Y., Taira, Y., & Takamura, N. (2023). Latest Topics of Interest on Radiation Risk Communication: A Decade After Japan’s Fukushima Daiichi Nuclear Power Plant Accident. Disaster Medicine and Public Health Preparedness. https://doi.org/10.1017/dmp.2023.194
Vancouver
Matsunaga H, Orita M, Xiao X, Kashiwazaki Y, Taira Y, Takamura N. Latest Topics of Interest on Radiation Risk Communication: A Decade After Japan’s Fukushima Daiichi Nuclear Power Plant Accident. Disaster Medicine and Public Health Preparedness. 2023. doi:10.1017/dmp.2023.194
BibTeX
@article{Matsunaga2023,
author = {Matsunaga, Hitomi and Orita, Makiko and Xiao, Xu and Kashiwazaki, Yuya and Taira, Yasuyuki and Takamura, Noboru},
title = {Latest Topics of Interest on Radiation Risk Communication: A Decade After Japan’s Fukushima Daiichi Nuclear Power Plant Accident},
journal = {Disaster Medicine and Public Health Preparedness},
year = {2023},
doi = {10.1017/dmp.2023.194}
}
EUVIMED